# US 2026/0015326 A1 · Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0015326 A1
- Document ID: US20260015326A1
- Status: Published application
- Kind: A1
- Application number: 19/334,675
- Filed: 2025-09-19
- Published: 2026-01-15
- Earliest claimed: 2018-03-26
- Assignees: Bayer Aktiengesellschaft
- Applicants: Bayer Aktiengesellschaft
- Inventors: Christoph SCHOTES; Dirk Eckart BROHM; Johannes SCHRANCK
- Web page: https://patentgrep.com/patent/US20260015326A1

## CPC

- C07D 215/08: with acylated ring nitrogen atom
- B01J 31/189: {containing both nitrogen and phosphorus as complexing atoms, including e.g. phosphino moieties, in one at least bidentate or bridging ligand}
- B01J 31/2295: {Cyclic compounds, e.g. cyclopentadienyls}
- B01J 31/2404: {Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring}
- B01J 31/2447: {and phosphine-P atoms as substituents on a ring of the condensed system or on a further attached ring}
- B01J 2231/645: of C=C or C-C triple bonds
- B01J 2531/0205: Bi- or polynuclear complexes, i.e. comprising two or more metal coordination centres, without metal-metal bonds, e.g. Cp(Lx)Zr-imidazole-Zr(Lx)Cp
- B01J 2531/827: Iridium
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

The invention relates to a process for preparing optically active 4-substituted 1,2,3,4-tetrahydroquinolines comprising enantioselective hydrogenation of the corresponding 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium (P,N)-ligand catalyst.

## Claims

### Claim 1

A process for preparing a compound of the formula (Ia) or (Ib),
wherein
R1 is C1-C6-alkyl,
R2 and R3 are the same and are selected from the group consisting of C1-C6-alkyl,
R4 is C1-C6-alkyl,
n is 0 or 1,
each substituent R5, if present, is independently selected from the group consisting of halogen, comprising enantioselective hydrogenation of a compound of the formula (II)
wherein the substituents R1, R2, R3, R4, R5 and the integer n are each as defined for the compound of the formula (Ia) or (Ib),
in presence of a chiral iridium catalyst,
characterized in that the chiral iridium catalyst comprises a chiral ligand of the formula (IIIa) or (IIIb)
wherein
R6 and R7 are independently from one another selected from consisting of hydrogen, C1-C6-alkyl, and C6-C14-aryl,
wherein the C6-C14-aryl is optionally substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, and C1-C4-alkoxy,
R8 is methyl,
R9 and R10 are independently from one another selected from the group consisting of C1-C6-alkyl, and C3-C12-cycloalkyl, and
m is 1 or 2.

### Claim 2 (depends on 1)

The process according to claim 1, wherein
R2 and R3 are the same and are selected from C1-C4-alkyl, and
R4 is C1-C4-alkyl.

### Claim 3 (depends on 1)

The process according to claim 1, wherein
R1 is methyl, ethyl or n-propyl,
R2 and R3 are methyl, and
R4 is C1-C4-alkyl.

### Claim 4 (depends on 1)

The process according to claim 1, wherein the chiral iridium catalyst comprises a chiral ligand of the formula (IIIa) or (IIIb), wherein
R6 is C6-C14-aryl, wherein the C6-C14-aryl is unsubstituted or substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, and C1-C4-alkoxy,
R7 is selected from the group consisting of hydrogen, and C1-C6-alkyl, and
R9 and R10 are independently from one another selected from the group consisting of C1-C6-alkyl, and C3-C12-cycloalkyl.

### Claim 5 (depends on 1)

The process according to claim 1, wherein the chiral iridium catalyst comprises a chiral ligand of the formula (IIIa) or (IIIb), wherein
R6 is selected from the group consisting of 1-naphtyl, 2-naphtyl, 9-antracenyl, 9-phenantryl or phenyl, which is unsubstituted or substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkoxy, C1-C4-alkyl, and C1-C4-haloalkyl,
R7 is hydrogen or C1-C6-alkyl, and
R9 and R10 are independently from one another selected from the group consisting of ethyl, iso-propyl, sec-butyl, iso-butyl, tert-butyl, cyclohexyl, cyclopentyl, and adamantyl.

### Claim 6 (depends on 1)

The process according to claim 1, wherein the hydrogenation is conducted using hydrogen gas at a pressure of from 1 to 300 bar.

### Claim 7 (depends on 1)

The process according to claim 1, wherein the amount of iridium catalyst used is within the range of from 0.001 mol % to 5 mol %, based on the amount of the compound of the formula (II).

### Claim 8 (depends on 1)

The process according to claim 1, wherein the hydrogenation is conducted at a temperature within the range of from 20° C. to 130° C.

### Claim 9 (depends on 1)

The process according to claim 1, wherein the hydrogenation is conducted in presence of a solvent selected from the group consisting of 2,2,2-trifluoroethanol, 1,1,1,3,3,3-hexafluoro-2-propanol, 1,2-dichloroethane, tetrafluoropropanol, and mixtures thereof.

### Claim 10 (depends on 1)

The process according to claim 1, wherein the chiral iridium catalyst has the formula (Va), or (Vb):
wherein
R6 is selected from the group consisting of 1-naphtyl, 2-naphtyl, 9-antracenyl, 9-phenantryl or phenyl,
wherein 1-naphtyl, 2-naphtyl, 9-antracenyl, 9-phenantryl and phenyl are unsubstituted or substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkoxy, C1-C4-alkyl, and C1-C4-haloalkyl,
R7 is hydrogen or C1-C6-alkyl,
R8 is methyl,
R9 and R10 are independently from one another selected from the group consisting of ethyl, iso-propyl, sec-butyl, iso-butyl, tert-butyl, cyclohexyl, cyclopentyl, and adamantyl, and
R18 is phenyl, which is unsubstituted or substituted with one to five substituents selected from group consisting of fluorine and C1-C4-haloalkyl.

### Claim 11 (depends on 10)

The process according to claim 10, wherein
R6 is selected from the group consisting of phenyl, 2,6- or 3,5-dimethylphenyl, 2,4,6-trimethylphenyl, 4-tert-butylphenyl, 4-methoxyphenyl, 3,5-bis-tert-butyl-4-methoxyphenyl, 4-tert-butyl-2,6-dimethylphenyl, 4-fluorophenyl, 4-trifluoromehtylphenyl, 1-naphtyl, 9-antracenyl 2,4,6-triisopropylphenyl, 9-phenantryl or 2,6-diethyl-4-methylphenyl,
R7 is hydrogen, and
R9 and R10 are each the same and tert-butyl, adamantly, cyclopentyl or cyclohexyl.

### Claim 12 (depends on 1)

The process according to claim 1, wherein the chiral iridium catalyst comprises a chiral ligand of the formula (IIIa) or (IIIb), wherein
R6 is selected from the group consisting of 1-naphtyl, 2-naphtyl, 9-antracenyl, 9-phenantryl or phenyl, which is unsubstituted or substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkoxy, C1-C4-alkyl, C1-C4-haloalkyl and phenyl, wherein the phenyl again is unsubstituted or substituted by one to five C1-C6-alkyl substituents, is hydrogen or C1-C6-alkyl, and R7
R9 and R10 are independently from one another selected from the group consisting of ethyl, iso-propyl, sec-butyl, iso-butyl, tert-butyl, cyclohexyl, cyclopentyl, and adamantyl.

### Claim 13 (depends on 12)

The process according to claim 12, wherein
R6 is selected from the group consisting of phenyl, 2,6- or 3,5-dimethylphenyl, 2,4,6-trimethylphenyl, 4-tert-butylphenyl, 4-methoxyphenyl, 3,5-bis-tert-butyl-4-methoxyphenyl, 4-tert-butyl-2,6-dimethylphenyl, 4-fluorophenyl, 4-trifluoromehtylphenyl, 1-naphtyl, 9-antracenyl 2,4,6-triisopropylphenyl, 9-phenantryl or 2,6-diethyl-4-methylphenyl,
R7 is hydrogen
R9 and R10 are each the same and tert-butyl, cyclopentyl or cyclohexyl, and
m is 1.

### Claim 14 (depends on 1)

The process according to claim 1, wherein the chiral iridium catalyst comprises a chiral ligand of the formula (IIIa) or (IIIb), wherein
R6 is selected from the group consisting of phenyl, 2,6- or 3,5-dimethylphenyl, 2,4,6-trimethylphenyl, 4-tert-butylphenyl, 4-methoxyphenyl, 3,5-bis-tert-butyl-4-methoxyphenyl, 4-tert-butyl-2,6-dimethylphenyl, 4-fluorophenyl, 4-trifluoromehtylphenyl, 1-naphtyl, 9-antracenyl, 2,4,6-triisopropylphenyl, 9-phenantryl and 2,6-diethyl-4-methylphenyl,
R7 is hydrogen,
R9 and R10 are independently from one another selected from the group consisting of ethyl, iso-propyl, sec-butyl, iso-butyl, tert-butyl, cyclohexyl, cyclopentyl, and adamantyl, and
m is 1.
